Pinney & Scofield’s Pfizer PFE Stock Holding History

Pinney & Scofield’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$128K	Hold	5,321	–	–	0.06%	71
2026 Q1	$149K	Hold	5,321	–	–	0.08%	65
2025 Q4	$132K	Hold	5,321	–	–	0.08%	64
2025 Q3	$136K	Hold	5,321	–	–	0.08%	59
2025 Q2	$129K	Hold	5,321	–	–	0.09%	65
2025 Q1	$135K	Hold	5,321	–	–	0.1%	61
2024 Q4	$141K	Buy	+5,321	New	+$144K	0.11%	59

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Pinney & Scofield's PFE Position: Q2 2026 in Review

Pinney & Scofield held its Pfizer (PFE) position steady in Q2 2026 at 5,321 shares worth $128K. The position accounts for 0.06% of the portfolio, ranked #71.

Pinney & Scofield first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $149K in Q1 2026. 2,832 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Pinney & Scofield held 5,321 shares of Pfizer worth $128K as of Q2 2026.
Pinney & Scofield left its Pfizer share count unchanged in Q2 2026.
Pfizer made up 0.06% of Pinney & Scofield's portfolio in Q2 2026, its #71 holding.
Pinney & Scofield first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
Pinney & Scofield's Pfizer position peaked at $149K in Q1 2026.
2,832 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Pinney & Scofield's 13F filing for Q2 2026, filed 7 Aug 2026.